VISTN — Vistin Pharma ASA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual balance sheet for Vistin Pharma ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	—	—	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	35.7	1.44	26.2	12.8	16.4
Net Total Accounts Receivable
Net Total Receivables	43.1	71.2	59.6	52	105
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	138	159	169	143	204
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	167	219	220	230	224
Long Term Investments
Other Long Term Assets
Total Assets	333	407	403	385	439
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	41	118	69.5	64	79
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	57.4	134	80.6	75.4	111
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	276	273	323	310	329
Total Liabilities & Shareholders' Equity	333	407	403	385	439
Total Common Shares Outstanding